MediWound Ltd. (MDWD)
NASDAQ: MDWD · Real-Time Price · USD
15.95
-1.03 (-6.07%)
At close: Mar 28, 2025, 4:00 PM
15.84
-0.11 (-0.69%)
After-hours: Mar 28, 2025, 5:52 PM EDT
MediWound Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for MediWound stock have an average target of 32, with a low estimate of 25 and a high estimate of 39. The average target predicts an increase of 100.63% from the current stock price of 15.95.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for MediWound stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 1 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +56.74% | Mar 20, 2025 |
Craig-Hallum | Craig-Hallum | Strong Buy Initiates $39 | Strong Buy | Initiates | $39 | +144.51% | Feb 28, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +56.74% | Jan 10, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $28 → $25 | Strong Buy | Maintains | $28 → $25 | +56.74% | Nov 27, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +75.55% | Oct 11, 2024 |
Financial Forecast
Revenue This Year
25.86M
from 20.22M
Increased by 27.86%
Revenue Next Year
32.21M
from 25.86M
Increased by 24.57%
EPS This Year
-2.95
from -3.03
EPS Next Year
-2.44
from -2.95
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 28.6M | 35.1M | 84.8M | ||
Avg | 25.9M | 32.2M | 66.0M | ||
Low | 23.5M | 29.4M | 47.7M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 41.3% | 35.8% | 163.3% | ||
Avg | 27.9% | 24.6% | 105.0% | ||
Low | 16.3% | 13.7% | 48.2% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -2.85 | -2.08 | -1.22 | ||
Avg | -2.95 | -2.44 | -1.64 | ||
Low | -2.90 | -2.73 | -2.01 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.